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STUDIES carried out on patients with malignant disease have demonstrated
that operative manipulation of a malignant tumour releases cancer cells into the
circulation, frequently in considerable number (Moore, Sandberg and Watne,
1960; Cole, McDonald, Roberts and Southwick, 1961). It is, therefore, of
considerable importance during operation to avoid, as far as is possible, any
procedure which will promote the development of tumour metastases from these
circulating cancer cells.
Many operations for malignant disease entail extensive and lengthv surgical
procedures and it has become common practice for patients submitted to this
type of surgery to receive intravenous fluids during the course of the operation.
The intravenous infusion apparatus, frequently set up some hours before operation,
can be used for blood transfusions should this be required. For the purpose of
fluid replacement it may be retained for a few days after operation. When
blood is not being used, under different circumstances various fluids may be
infused into the patient. Little is known about the effect of intravenous fluids
on cancer cells and, in particular, the influence these solutions may have on the
metastatic potential of circulating cancer cells.
It is the purpose of this experimental study to determine the effect both
in vitro and in vivo offour clinically available intravenous solutions on cell suspen-
sions of the Walker 256 tumour system. Because it is established that tumour
cell aggregates are more liable to give rise to metastases than single circulating
cancer cells (Watanabe, 1954) particular attention has been paid to the aggregating
effect of the intravenous fluids on the experimental tumour cells.
METHODS
In the present series of experiments the Walker 256 tumour was used in the
form of a suspension of single tumour cells prepared by a modification of the
method described by Rodin, Turner and Couves (1963). The tumour cells were
suspended in Hank's balanced salt solution (BSS).
Four intravenous solutions were used:
1. Dextraven (Benger Laboratories Ltd.)-a sterile solution of 10% w/v
dextran, having an average molecular weight of 150,000, in 5% dextrose solution.
It is designated a high molecular weight dextran (HMWD) solution.
2. Rheomacrodex (Pharmacia G.B. Ltd.)-a sterile solution of 10% w/v
dextran, having an average molecular weight of 40,000, in 5% dextrose solution.
It is designated a low molecular weight dextran (LMWD) solution.EXPERIMENTAL TUMOUR METASTASES
3. A sterile dextrose solution containing 50 g. of dextrose/litre of water (5%
dextrose).
4. A sterile salt solution containing 9 g. of sodium chloride/litre of water
(0.9% sodium chloride).
Both Dextraven and Rheomacrodex are prepared commercially with the
dextran fractions suspended either in 0-9% sodium chloride or in 5% dextrose.
However, as dextrans cause an anaphylactoid reaction in rats which can be
effectively overcome by dextrose (Beraldo, Da Silva and Fernandes, 1962), the
dextrose suspended dextran solutions were used in this investigation.
The investigation was divided into three parts. The in vitro studies were
carried out at room temperature.
(1) Microscope studies
Six Walker 256 tumour cell suspensions containing 25,000 cells/c.mm., 30,000
cells/c.mm., 40,000 cells/c.mm., 65,000 cells/c.mm., 75,000 cells/c.mm. and 90,000
cells/c.mm. were used. At each of these cell concentrations a single drop of the
suspension was placed on each of five clean glass microscope slides. One drop
of the four intravenous solutions under investigation and one drop of Hank's
BSS was then placed in contact with the cell suspension on the glass slides, one
solution to a slide. The two drops on each slide were gently mixed together and
a coverslip placed over the fluid. With the slides horizontally placed on the
microscope stage, microscopic examination of the cells was then undertaken.
(2) Estimation of tumour cell sedimentation rates
The six Walker 256 tumour cell suspensions prepared for the microscope
study were also used to determine tumour cell sedimentation rates. At each
cell concentration a total of 5 ml. of suspension was used. This was divided
equally into five clean glass test-tubes, 1 ml. to each tube. To the first test-tube
was added 1 ml. of Dextraven, to the second 1 ml. of Rheomacrodex, to the
third 1 ml. of0.9% sodium chloride, to the fourth 1 ml. of5% dextrose and 1 ml.
of Hank's BSS was added to the fifth tube. The tubes were shaken to ensure
uniform mixing ofthe solutions with the cell suspension. The resulting prepara-
tions were drawn up to the zero mark ofstandard Westergren sedimentation tubes
of 200 gradations and 2-5 mm. internal diameter. These tubes were then clipped
into racks, care being taken to ensure that they were vertically placed. The rate
of cell sedimentation was read every thirty minutes for the first two hours and
thereafter hourly for a total period of nine hours. Because of the decrease in
viability of tumour cells with time observations were not continued beyond the
nine hour period.
(3) In vivo studies
Female albino Sprague-Dawley rats obtained from the Oxfordshire Laboratory
Animal Colonies were used. They weighed between 160-200 g. at the beginning
ofthe experiment. Housed six animal to a cage, they were fed a standard cubed
diet and supplied with water ad libitum.
Three sterile single tumour cell suspensions containing 60,000 cells/c.mm.,
30,000 cells/c.mm. and 20,000 cells/c.mm. were prepared.
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In this investigation all injections were given under ether anaesthesia into the
saphenous vein found in the inner aspect of the hind limb of the rat usinlg a
20-gauge intravenous needle.
The animals were divided at random into three groups with thirty rats in
each group.
In the first group of thirty rats the first rat was given a slow intravenous
injection of 1 ml. of Dextraven and this was followed one minute later by an
intravenous injection of 60,000 Walker 256 tumour cells in 0-1 ml. of Hank's
BSS. The second rat was similarly treated but was given 1 ml. ofRheomacrodex
in place of 1 ml. of Dextraven. The third, fourth and fifth rats were treated in
an identical manner, the Dextraven being replaced by 1 ml. of 0-9% sodium
chloride, 1 ml. of 5% dextrose and 1 ml. of Hank's BSS, respectively. This
injection sequence was repeated five more times giving a total of six rats injected
with each intravenous solution under investigation and six rats injected with
Hank's BSS.
In the second group of thirty rats the injection sequence used in the first
group of thirty rats was repeated but in this group a tumour cell suspension
containing 30,000 cells in 0-1 ml. of Hank's BSS was used in place of the tumour
cell suspension containing 60,000 cells in 0-1 ml. of Hank's BSS.
The third group of thirty rats was treated in an identical manner to the other
two groups ofrats but in this instance a tumour cell suspension containing 20.000
cells in 0-1 ml. of Hank's BSS was used.
All the rats were retained until death and the number ofsurvival days following
the intravenous injections were noted. The animals were then subjected to
careful post-mortem examination. Macroscopic appearances were noted and
selected tissues were excised for microscopic study.
RESULTS
(1) Microscope studies
At the higher cell concentrations used in this part ofthe investigation immedi-
ate aggregation of the tumour cells into a coherent cell mass was observed on
macroscopic examination of the microscope slides when the cell suspensions were
mixed with either of the dextran solutions, Dextraven or Rheomacrodex. On
examination of this coherent cell mass under the microscope it was found to be
composed of clumps of tumour cells, frequently comprising hundreds of cells,
connected by bridges of cells of varying thickness. With time these bridges of
cells gradually thinned out and finally broke apart leaving discrete compact
aggregates of cells. Pressure on the cover-slip did not cause the cell aggregates
to disperse into single cells but moved them as solid cell masses. At the lower
cell concentrations a similar sequence of events was observed when the tumour
cells were mixed with either Dextraven or Rheomacrodex. However, the cell
masses were smaller and the bridges of cells connecting them together were
thinner. These cellular bridges rapidly broke apart to leave small isolated
clumps of tumour cells. Although it was impossible to accurately assess the
number of tumour cells making up the discrete cell masses, overall the cell masses
appeared slightly larger in the tumour cell suspensions mixed with the HMWD
solution than in the tumour cell suspensions mixed with the LMWD solution.
Aggregation of the tumour cells was not observed when the cells were mixed
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with 0-9% sodium chloride, 5% dextrose or further mixed with Hank's BSS.
The cells spread evenly over the microscope slide. Occasionally a tendency to
form clumps was observed but gentle pressure on the cover-slip dispersed the
cells in the free state once more indicating that true cell aggregation had not
taken place.
(2) Estimation of tumour cell sedimentation rates
Within minutes ofsetting up the Westergren sedimentation apparatus obvious
aggregation of the tumour cells to form a coherent cell mass was observed in the
sedimentation tubes where the Walker 256 tumour cells had been mixed with
either Dextraven or Rheomacrodex. The cells formed a dense column in the
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FIG. 1.-The 1 hour sedimentation rates of various concentrations of Walker 256 tumour
cells suspended in different solutions.
middle of the tube surrounded by a zone of clear fluid. This effect was more
apparent at the higher cell concentrations. Cell aggregation was not observed
in the sedimentation tubes where the tumour cells had been mixed with 0.9%
sodium chloride, 5% dextrose or Hank's BSS.
The coherent mass of cells in the sedimentation tubes gradually broke down
to form discrete cell masses. Only after this had occurred did sedimentation
of the cells take place. At the lower tumour cell concentrations there was a
more rapid break down of the coherent cell mass into discrete cellular particles
than at the higher cell concentrations. This resulted in a progressive decrease
in the time of onset of sedimentation as the cell concentration fell from 90,000
cells/c.mm. to 25,000 cells/c.mm. In the three solutions where cell aggregation
was not observed, the tumour cells started to sediment as soon as the Westergren
tubes were fixed in place.
The one hour cell sedimentation rates recorded when the various concentra-
tions of Walker 256 tumour cells were mixed with the different solutions investi-
gated are shown in Fig. 1. The difference in cell sedimentation rate between
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those solutions which cause aggregation of the tumour cells and those solutions
which do not cause the tumour cells to aggregate is obvious, particularly at the
higher cell concentrations. Because ofthe delay in onset ofsedimentation caused
by aggregation ofthe tumour cells, the tumour cell suspensions mixed with either
ofthe dextran solutions had the lower readings after one hour. When the tumour
cells were mixed with 0-9% sodium chloride, 5% dextrose or Hank's BSS, between
concentrations of 90,000 cells/c.mm. and 40,000 cells/c.mm. the graphs of the
one hour sedimentation rates showed a linear relationship. This was not a feature
of the graphs of the one hour sedimentation rates of the tumour cells suspended
in either ofthe two dextran solutions. Below concentrations of40,000 cells/c.mm.
the linearity was lost, presumably because at these cell concentrations after one
hour the upward packing effect ofthe cells interfered with free cell sedimentation.
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FIG. 2.--The sedimentation rates recorded over 9 hours for three different concentrations of Walker
256 tumour cells suspended in either Dextraven or Rheomacrodex.
The sedimentation rate over a nine hour period for three different concentra-
tions of Walker 256 cells mixed with either Dextraven or Rheomacrodex are
shown graphically in Fig. 2. The graphs of the three other cell concentrations
suspended in either of the dextran solutions followed a similar pattern and have
been omitted from Fig. 2 for the sake ofclarity. The delay in onset ofsedimenta-
tion due to the aggregation of the cells into a coherent cell mass is obvious. It
is most marked at a concentration of 90,000 cells/c.mm., is present to a lesser
extent at a concentration of 65,000 cells/c.mm. and is least obvious at a cell
concentration of 40,000 cells/c.mm. At each cell concentration the onset of
sedimentation was longer delayed when the tumour cells had been mixed with
the HMVVD solution. Once initiated, cell sedimentation proceeded at almost the
same rate in both dextran solutions. Consequently the sedimentation curves
over the period of observation follow almost parallel lines with the sedimentation
rate for the Dextraven suspended cells always less, at any given time, than the
sedimentation rate for the tumour cells suspended in Rheomacrodex.
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(3) In vivo studies
All the rats survived the intravenous injections. During the injections a
transient rise in both the respiratory rate and the heart rate was noted but both
returned to normal within a few minutes of completing the injections. Obvious
histamine shock was not observed in any of the animals.
The mean survival time in days and the standard deviation for each group of
six rats is shown in Table I. At each of the three cell concentrations used in
TABLE I.-The Mean Survival Times and Standard Deviations in Days of Groups
of Six Rats Injected with 1 ml. of Various Intravenous Fluids Followed by the
Intravenous Injection of Walker 256 Tumnour Cells.
Number of tumour cells injected
intravenously
Intravenous fluids: 60,000 30,000 20,000
Hank's BSS . 16.5±4.9 20-7±1-0 26-5±1-6
Saline 0 9% . 9-4+1-6 21-3+1-9 27-0±1-9
Dextrose 5% . 8-9±1-9 212±1-9 26-0±1d1
Rheomacrodex . 8&2±09 15 5+0 9 19*1±1i1
Dextraven . . 7x8±1*0 15 2±i14 18i7±0*7
this part of the investigation the animals treated with either of the two dextran
solutions were the first to die when comparison was made with the death rate of
the animals injected with the three other solutions. This difference was not
so apparent at a cell concentration of 60,000 cells/c.mm., but was obvious at the
other two cell concentrations used. There was no significant difference in survival
time between the rats treated with Dextraven and the rats treated with Rheo-
macrodex.
In each group of six rats all the animals died within a few days of each other
with the exception of the rats injected with 1 ml. of Hank's BSS intravenously
followed by 60,000 tumour cells. In this group two animals survived for a
considerably longer period oftime than the remaining four rats thereby increasing
the mean survival figure. With this exception, the rats treated with 0.9%
sodium chloride, 5% dextrose or Hank's BSS survived for approximately the
same number ofdays at each ofthe three different cell concentrations investigated.
All the animals died from extensive pulmonary deposits of the Walker 256
carcinosarcoma. These deposits were so extensive that it was frequently difficult
to identify normal lung tissue either macroscopically or microscopically in many
ofthe specimens examined. No apparent difference in the pattern of metastases
was found between the rats treated with Dextraven or Rheomacrodex and the
ratstreated withthe otherthree solutions. Macroscopic andmicroscopicexamina-
tion ofother organs taken from the rats failed to demonstrate tumour metastases
at any other site.
DISCUSSION
The two dextran solutions used in this investigation, Dextraven and Rheo-
macrodex, aggregated the experimental Walker 256 tumour cells in vitro. This
property of tumour cell aggregation was not exhibited by 0.9% sodium chloride,
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500, dextrose or by Hank's BSS. The dextrans were suspended in 5 O dextrose
and the Walker 256 tumour cells were suspended in a small volume of Hank's
BSS. As neither of these solutions caused the tumour cells to aggregate, the cell
aggregation effected by the two dextran solutions must be attributed directly
to the dextran fractions.
It may be assumed that the sequence of events observed macroscopically in
the Westergren sedimentation tubes parallels the sequence of events observed
on the microscope slides when the experimental tumour cells were mixed with
either of the dextran solutions. In the sedimentation tubes the cancer cells
initially formed a coherent cell mass consisting of zones of aggregated cells joined
by bridges of cells of varying thickness. Only after these bridges had disrupted
did cell sedimentation start. According to Thorsen and Hint (1950), in studying
any cell suspension where there is a strong aggregating tendency it is always
possible to distinguish a distinct phase of aggregation and a distinct phase of
sedimentation in the column of cells in a sedimentation tube. From the observa-
tions made in the present experiment it is apparent that both HMWD and LMWD
exerted a strong aggregating effect on the Walker 256 tumour cells used in this
investigation. As it was found that the onset of sedimentation was always
longer delayed when the tumour cells were mixed with Dextraven compared with
the same tumour cell concentration mixed with Rheomacrodex, HMWD must
hold the cellular bridges intact between the zones of aggregated cells for a longer
time than LMWD. Therefore, HMWD must exert a more prolonged initial
aggregating effect on the experimental tumour cells than LMWD.
The chief factor influencing the rate of sedimentation is the size of the sedi-
menting particle (Wintrobe, 1951). On microscope examination HMWD appeared
to produce cell aggregates composed of a larger number of cells than LMWD,
although absolute comparisons were impossible due to the difficulty experienced
in counting the number of cancer cells in each aggregate with any degree of
accuracy. Study of the cell sedimentation rates over nine hours demonstrated
that, while there was a greater delay in onset of sedimentation in the Dextraven
suspended tumour cells, once sedimentation had started the hourly rate ran
almost parallel to the hourly rate of sedimentation for the tumour cells mixed
with Rheomacrodex. The sedimentation rate of the tumour cells in the HMWD
solution never exceeded, at any given time, the sedimentation rate for the tumour
cells in the LMWD solution, a result to be expected had there been a pronounced
difference in the size of the sedimenting aggregates of cancer cells. From these
results it can be deduced that, although HMWD exerts a more prolonged initial
aggregating effect on the experimental tumour cells as determined by the greater
delay in onset of sedimentation when compared with LMWD, once this effect
had passed off the cell aggregates finally produced by the two dextran solutions
used in this investigation are approximately the same size.
Study of the mean survival time of the rats used in this investigation demon-
strated that, at each of the three tumour cell concentrations used, the first rats
to die from diffuse pulmonary metastases were the rats injected intravenously
with either of the dextran solutions before the intravenous injection of cancer
cells. It is apparent, therefore, that under the conditions of this investigation
the dextran solutions promoted the development of tumour metastases. To
understand how this could be effected it is necessary to consider the steps in the
formation of blood-borne tumour metastases. To produce tumour metastases
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circulating cancer cells must first be arrested at some site within the vascular
network. They must then establish themselves at the site of arrest and this is
associated with thrombus formation around the lodged cells (El Rifi, Bacon,
Mehigan, Hoppe and Cole, 1965). Finally the cells undergo division to produce
overt tumour metastases. It has been shown that in blood dextrans of high
molecular weight induce coagulation defects and that dextrans of low molecular
weight do not produce any significant change in the coagulation mechanism
(Seaman, Hissen, Lino and Swank, 1965). It is unlikely, therefore, that these
colloids could promote the process ofmetastases formation at the stage ofestablish-
ment of the lodged cancer cells for this would imply that the dextrans had aug-
mented the coagulation mechanism. Neither can dextrans influence the process
of metastases formation at the stage when the established cells are undergoing
division. Not only have dextrans been shown to have a slight cytotoxic effect
on dividing cancer cells (Powell, 1961) which would, in effect, inhibit the develop-
ment of tumour metastases but it is also unlikely that the dextrans would be
retained within the circulation for a sufficient length of time to influence the
cancer cells at this stage in the process of metastases formation. It is reasonable
to conclude that dextrans promote the development of tumour metastases by
increasing the arrest of circulating cancer cells and in the rats used in this investi-
gation the site of tumour cell arrest was within the pulmonary circulation.
Within the circulation aggregates of cancer cells are more liable to give rise
to metastases than single cancer cells (Watanabe, 1954). Taking into considera-
tion the results ofthe in vitro studies, it is tempting to postulate that the increased
metastatic potential of circulating cancer cells in rats treated with dextrans is a
direct result of intravascular aggregation of these cells. That there was little
difference in the size of the cell aggregates produced by HMWD and LMWD taken
in associationwith the findingthat there wasnosignificantdifference inthe survival
time ofthe rats pretreated with HMWD or LMWD before injection ofthe tumour
cells adds support to a theory ofintravascular tumour cell aggregation. However,
other factors require consideration. It is necessary to consider the possibility
of a stress reaction in the dextran treated rats. Stress in any form increases
the susceptibility of tissues to the implantation of malignant cells (Griffiths,
1960). Dextrans cause an anaphylactoid reaction in rats (Voorhees, Baker and
Pulaski, 1951) and this may be regarded as a form of stress. By using dextrans
suspended in 500 dextrose this reaction was apparently prevented. However,
the possibility that some degree of anaphylaxis was present but was unrecognised
in the dextran treated rats cannot be entirely discounted. The effect of dextrans
on blood vessels also requires consideration. Not only do dextrans form a
surface coating on the cellular elements ofthe blood but they also coat the luminal
surface of blood vessels (Bloom, Harmer, Bryant and Brewer, 1964). By increas-
ing the stickiness of the intima in this way the arrest of circulating tumour cells,
also coated with dextran, may be promoted. Within the limits of this investiga-
tion it is not possible to determine the exact mechanism responsible for the
increased arrest of circulating cancer cells within the pulmonary circulation in
rats when dextrans are present in the circulation. This problem is being investi-
gated further.
These results would seem to indicate that careful consideration should be
given to the use of intravenous dextran solutions in patients with malignant
disease, particularly at times when cancer cells may be free within the circulation.
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SUMMARY
By means ofmicroscope studies and tumour cell sedimentation rate determina-
tions it has been demonstrated that solutions of high molecular weight dextran
(Dextraven) and solutions of low molecular weight dextran (Rheomacrodex)
effected the aggregation of cell suspensions of the Walker 256 rat carcinosarcoma
in vitro. This effect was not observed when the tumour cells were mixed with
either 0 9% sodium chloride or 5%0 dextrose.
It was further demonstrated that dextrans of either high molecular weight or
low molecular weight promoted the development of tumour metastases from
circulating cancer cells, probably by increasing the intravascular arrest of these
cancer cells.
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